This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Surging Earnings Estimates Signal Good News for OraSure (OSUR)
by Zacks Equity Research
OraSure (OSUR) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
5 Top Stocks with Upgraded Broker Ratings to Bet On
by Zacks Equity Research
When brokers upgrade a stock, you can rely on their judgment.
Stock Market Roundup, Feb. 14: Stocks Spread the Love on Valentine's Day
by Ryan McQueeney
Valentine's Day is not everyone???s favorite holiday, but investors should be pleased either way after a relatively solid day on the stock market.
Zacks.com featured highlights: Brooks Automation, United States Steel, Everest Re Group, OraSure Technologies and Soffa Industries and TTM Technologies
by Zacks Equity Research
Zacks.com featured highlights: Brooks Automation, United States Steel, Everest Re Group, OraSure Technologies and Soffa Industries and TTM Technologies
Want to Gain from Relative Price Strength? 5 Stocks to Buy
by Nilanjan Choudhury
We ran a screen to select the top 5 stocks with solid relative price strength you want to have.
AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Lag
by Zacks Equity Research
AmerisourceBergen Corporation (ABC) posted earnings (excluding one-time items) of $1.36 per share in the first quarter of fiscal 2017, beating the Zacks Consensus Estimate of $1.24.
Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
by Zacks Equity Research
Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
Hill-Rom (HRC) Q1 Earnings Meet, Revenues Lag Estimates
by Zacks Equity Research
Hill-Rom Holdings, Inc. (HRC) reported first-quarter fiscal 2017 adjusted earnings per share of 75 cents, up 10.3% from the year-ago quarter.
Abaxis (ABAX) Q3 Bleak: Earnings In Line, Revenues Miss
by Zacks Equity Research
Abaxis, Inc. (ABAX) - a global provider of point-of-care blood analyzers - reported third-quarter fiscal 2017 earnings per share of 30 cents, in line with the Zacks Consensus Estimate.
5 Efficient Stocks Potent Enough to Boost Your Returns
by Zacks Equity Research
A portfolio built by investing in efficient companies is capable of generating profits irrespective of market conditions.
Cardiovascular Systems (CSII) Q2 Earnings Better Estimates
by Zacks Equity Research
Cardiovascular Systems, (CSII) reported earnings per share of 3 cents in second-quarter fiscal 2017, reflecting a massive improvement from the year-ago quarter's loss of 47 cents.
Mead Johnson (MJN) Misses Q4 Earnings, Sales; Guides '17
by Zacks Equity Research
Mead Johnson (MJN) reported fourth-quarter 2016 adjusted EPS of 78 cents, missing the Zacks Consensus Estimate of 83 cents by 6%.
Quest Diagnostics (DGX) Tops Q4 Earnings, Offers '17 View
by Zacks Equity Research
Quest Diagnostics' (DGX) fourth-quarter 2016 adjusted earnings per share (EPS) of $1.31 came in 4 cents ahead of the Zacks Consensus Estimate.
PetMed (PETS) Lags Q3 Earnings Estimates, Tops Revenues
by Zacks Equity Research
PetMed Express (PETS) announced earnings per share (EPS) of 24 cents for the third quarter of fiscal 2017.
Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line
by Zacks Equity Research
Abbott Laboratories (ABT) reported fourth-quarter 2016 earnings from continuing operations of 65 cents per share, a penny higher than the Zacks Consensus Estimate.
ResMed (RMD) Beats Earnings and Revenue Estimates in Q2
by Zacks Equity Research
ResMed Inc. (RMD) announced second-quarter fiscal 2017 adjusted earnings per share (EPS) of 73 cents, consistent with the prior-year quarter level.
Bull of the Day: OraSure (OSUR)
by Brian Bolan
This stock is the perfect example of the post earnings drift even after a huge move on the earnings report.
A Company's First Profit Can Mean Big Profits to Investors
by Kevin Matras
Kevin Matras screens for companies showing their 'first' profit, and explains why they are ones to watch. Highlighted stocks include OPHT, XNPT, OSUR, INCY and AGIO.